Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecularly targeted drug combinations demonstrate selective effectiveness for myeloid- and lymphoid-derived hematologic malignancies
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 36, Pages E7554-E7563
Publisher
Proceedings of the National Academy of Sciences
Online
2017-08-08
DOI
10.1073/pnas.1703094114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Petri Net Siphon Analysis and Graph Theoretic Measures for Identifying Combination Therapies in Cancer
- (2018) Behnam Behinaein et al. IEEE-ACM Transactions on Computational Biology and Bioinformatics
- The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism
- (2016) M. A. Anderson et al. BLOOD
- Update on rational targeted therapy in AML
- (2016) Danielle Shafer et al. BLOOD REVIEWS
- Finally, An Apoptosis-Targeting Therapeutic for Cancer
- (2016) C. M. Croce et al. CANCER RESEARCH
- Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia
- (2016) A. Polk et al. CLINICAL CANCER RESEARCH
- Combination dabrafenib and trametinib in the management of advanced melanoma with BRAFV600 mutations
- (2016) Lavinia Spain et al. EXPERT OPINION ON PHARMACOTHERAPY
- Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent
- (2016) Jessica T. Leonard et al. Journal of Hematology & Oncology
- Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
- (2016) Andrew W. Roberts et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting BCL-2 and ABL/LYN in Philadelphia chromosome–positive acute lymphoblastic leukemia
- (2016) Jessica T. Leonard et al. Science Translational Medicine
- Combined targeting of BCL-2 and BCR-ABL tyrosine kinase eradicates chronic myeloid leukemia stem cells
- (2016) Bing Z. Carter et al. Science Translational Medicine
- Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia
- (2016) Kami Maddocks et al. SEMINARS IN ONCOLOGY
- Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
- (2016) M. Konopleva et al. Cancer Discovery
- Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression
- (2016) Giovanni Galletti et al. Cell Reports
- Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States
- (2015) Bruno C. Medeiros et al. ANNALS OF HEMATOLOGY
- Therapeutically Targetable ALK Mutations in Leukemia
- (2015) Julia E. Maxson et al. CANCER RESEARCH
- Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis
- (2015) J. E. Maxson et al. CANCER RESEARCH
- The combination of FLT3 and DNA methyltransferase inhibition is synergistically cytotoxic to FLT3/ITD acute myeloid leukemia cells
- (2015) E Chang et al. LEUKEMIA
- BH3 profiling identifies heterogeneous dependency on Bcl-2 family members in multiple myeloma and predicts sensitivity to BH3 mimetics
- (2015) C Touzeau et al. LEUKEMIA
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Database of Genomic Biomarkers for Cancer Drugs and Clinical Targetability in Solid Tumors
- (2015) Rodrigo Dienstmann et al. Cancer Discovery
- Identification of small molecules that support human leukemia stem cell activity ex vivo
- (2014) Caroline Pabst et al. NATURE METHODS
- The new frontier of genome engineering with CRISPR-Cas9
- (2014) J. A. Doudna et al. SCIENCE
- Genomic impact of transient low-dose decitabine treatment on primary AML cells
- (2013) J. M. Klco et al. BLOOD
- Ponatinib in patients with refractory acute myeloid leukaemia: findings from a phase 1 study
- (2013) Neil P. Shah et al. BRITISH JOURNAL OF HAEMATOLOGY
- Emergence of Polyclonal FLT3 Tyrosine Kinase Domain Mutations during Sequential Therapy with Sorafenib and Sunitinib in FLT3-ITD-Positive Acute Myeloid Leukemia
- (2013) S. D. Baker et al. CLINICAL CANCER RESEARCH
- Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibition
- (2013) Matthew S. Davids et al. LEUKEMIA & LYMPHOMA
- Oncogenic CSF3R Mutations in Chronic Neutrophilic Leukemia and Atypical CML
- (2013) Julia E. Maxson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Landscapes and Clonality of De Novo AML
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
- (2013) R. Pan et al. Cancer Discovery
- Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
- (2013) T. Pemovska et al. Cancer Discovery
- Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways
- (2013) Jing Tang et al. PLoS Computational Biology
- Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
- (2012) C. H. Man et al. BLOOD
- BH3 profiling – Measuring integrated function of the mitochondrial apoptotic pathway to predict cell fate decisions
- (2012) Victoria Del Gaizo Moore et al. CANCER LETTERS
- Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening
- (2012) J. W. Tyner et al. CANCER RESEARCH
- Circulating Tumor Cells: Liquid Biopsy of Cancer
- (2012) C. Alix-Panabieres et al. CLINICAL CHEMISTRY
- Survival for older patients with acute myeloid leukemia: a population-based study
- (2012) B. Oran et al. HAEMATOLOGICA
- Dynamic Single-Cell Network Profiles in Acute Myelogenous Leukemia Are Associated with Patient Response to Standard Induction Therapy
- (2010) S. M. Kornblau et al. CLINICAL CANCER RESEARCH
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- RNAi screen for rapid therapeutic target identification in leukemia patients
- (2009) J. W. Tyner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
- (2008) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now